Nursing Care According to Functional Health Patterns of Patients With Cholangiocarcinoma Cancer Receiving Nab-Paclitaxel, Gemcitabine Treatment: Case Report

Year 2024, Volume: 7 Issue: 1, 266 - 274, 25.03.2024

Zeliha Özkaraca , Sinem Toplar , Zeynep Günes

https://doi.org/10.38108/ouhcd.1249268

Abstract

Objective: This study aimed to plan nursing care according to the functional health patterns of a patient with cholangiocarcinoma cancer who received nab-paclitaxel and gemcitabine therapy.
Method: Observation, physical examination, and communication techniques were used for a patient with cholangiocarcinoma cancer who was receiving nab-paclitaxel gemcitabine treatment in oncology service. In addition, the patient was evaluated with Functional Health Patterns (FHP) and North America Nursing Diagnoses (NANDA), and a care plan was created.
Results: It was found that a 61-year-old male patient with cholangiocarcinoma, depending on the stage of the disease, his secondary problems affect his self-care, and there is a lack of information among caring family members. It was seen that the patient had an inadequacy in the way of cognitive perception and self-care skills.
Conclusion: Cholangiocarcinomas are the most common of biliary system malignant diseases, which usually do not show symptoms at the early stage and are unidentified, often resulting in death. In recent years, nab-paclitaxel, one of the cytotoxic agents, has been used in combination with gemcitabine to increase treatment effectiveness. It is seen that there are no resources to guide nurses about the side effects and care of these cytotoxic agents.

Keywords

Cholangiocarcinoma, nursing care, functional health patterns

Nab-Paclitaxel, Gemcitabine Tedavisi Alan Kolanjiyokarsinoma Kanseri Olan Hastanın Fonksiyonel Sağlık Örüntülerine Göre Hemşirelik Bakımı: Olgu Sunumu

Abstract

Amaç: Bu çalışmada, nab-paclitaxel, gemcitabine tedavisi alan kolanjiyokarsinoma kanseri olan hastanın fonksiyonel sağlık örüntülerine göre hemşirelik bakımının planlanması amaçlanmıştır.
Yöntem: Onkoloji servisinde yatmakta olan nab-paclitaxel, gemcitabine tedavisi alan kolanjiyokarsinoma kanseri olan hasta için gözlem, fizik muayene ve iletişim tekniği kullanıldı. Ayrıca hasta Fonksiyonel Sağlık Örüntüleri (FSÖ) ve North America Nursing Diagnoses (NANDA) ile değerlendirilerek bakım planı oluşturuldu.
Bulgular: Kolanjiokarsinom olan 61 yaşındaki erkek hastanın, hastalığın evresine bağlı olarak sekonder problemlerinin öz-bakımını etkilediği, bakım veren aile bireylerinde bilgi eksikliği olduğu saptandı. Hastanın bilişsel algılama biçiminde ve öz bakımını yerine getirme becerilerinde yetersizlik olduğu görüldü.
Sonuç: Kolanjiokarsinomalar, erken evrede genellikle belirti vermeyen ve tanımlanamayan, genellikle ölümle sonuçlanan biliyer sistem malign hastalıklarının en yaygınıdır. Son yıllarda tedavi etkinliğini arttırmak için sitotoksik ajanlardan nab-paclitaxel, gemcitabine kombine olarak kullanılmaktadır. Bu sitotoksik ajanların yan etkileri ve bakımı konusunda hemşirelere yol gösterecek kaynak bulunmadığı görülmektedir.

Keywords

Kolanjiyokarsinoma, hemşirelik bakımı, fonksiyonel sağlık örüntüleri

References

• Acquisto S, Iyer R, Rosati LM, Pinheirn N, Driskill K, Musto K ve ark. (2018). Cholangiocarcinoma Treatment, outcomes, and nutrition overview for oncology nurses. Clinical Journal of Oncology Nursing, 22(4), 97-102.
• Albrecht T A, Taylor A G. (2012). Physical activity in patients with advanced-stage cancer: a systematic review of the literature. Clinical Journal of Oncology Nursing, 16(3), 293-300.
• Al-Hajeili M, Azmi AS, Choi M. (2014). Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer. Onco Targets and Therapy, 7, 187–192.
• American Academy of Sleep Medicine. (2014). International Classification of Sleep International Classification of Sleep Disorders (Cilt 3rd ed.). Darien, IL: American Academy of Sleep Medicine.
• American Society Of Clinical Oncology. (2019). Bile Duct Cancer (Cholangiocarcinoma): Types of Treatment: Erişim Tarihi:12.11.2022, https://www.cancer.net/cancer-types/bile-duct-cancer -cholangiocarcinoma/introduction
• Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P ve ark. (2016). Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology, 13(5), 261-80.
• Bengi G, Yalçın M, Akpınar H. (2014). Kronik konstipasyona güncel yaklaşım. Güncel Gastroenteroloji, 72-88.
• Blechacz B. (2017). Cholangiocarcinoma: Current knowledge and new developments. Gut Liver, 11(1), 13–26.
• Blomstrand H, Scheibling U, Bratthäll C, Green H, Elander NO. (2019). Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer. BMC Cancer, 19(40), 1-9.
• Buysse DJ. (2014). Sleep health: can we define it? Does it matter? Sleep, 37(1), 9–17.
• Can G. (2018). Kanser Hastasında Kanıta Dayalı Palyatif Bakım. İstanbul: Nobel Tıp Kitabevleri.
• Christodoulides S, Dimidi E, Fragkos K C, Farmer A D, Whelan K, Scott S M. (2016). Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults. Alimentary Pharmacology & Therapeutics, 44(2), 103-211.
• Couch ME, Dittus K, Toth MJ, Willis MS, Guttridge DC, George JR ve ark. (2015). Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. Head & Neck, 37(4), 594–604.
• Dedeli Ö, Pakyüz SÇ. (2016). Bowel movement: the sixth vital sign? Clinical and Experimental Health Sciences, 6(3), 135-139.
• DeSouza S, Angelini D. (2021). Updated guidelines for immune thrombocytopenic purpura: Expanded management options. Cleveland Clinic Journal of Medicine, 88(12), 664-668.
• Fernandez-Rodriguez E J, Sanchez-Gomez C, Mendez-Sanchez R, Recio-Rodriguez J I, Puente-Gonzalez A S,
• Gonzalez-Sanchez J, Cruz-Hernandez JJ, Rihuete-Galve MI. (2023). Multimodal physical exercise and functional rehabilitation program in oncological patients with cancer-related fatigue - A randomized clinical trial. International Journal of Environmental Research and Public Health, 20(6):4938.
• Fong DYT, Ho JWC, Hui BPH, Lee AM, Macfarlane DJ, Leung SSK, Cerin E, Chan WYY, Leung IPF, Lam SHS, Taylot AJ, Cheng K. (2012). Physical activity for cancer survivors: meta-analysis of randomized controlled trials. British Medical Journal, 30, 344, e70.
• Ghouri YA, Mian I, Blechacz B. (2015). Cancer review: Cholangiocarcinoma. Journal of Carcinogenesis, 14(1), PMID: 25788866.
• Gulanick M, Myers JL. (2021). Nursing Care Plans: Diagnoses, Interventions, and Outcomes. Elsevier.
• Hachul H, Oliveir D, Bittencourt L, Andersen M, Tufikc S. (2014). The beneficial effects of massage therapy for insomnia in postmenopausal women. Sleep Science, 7, 114-116.
• Hemanth Mohandas SK. (2017). Cancer related fatigue treatment: An overview. Journal of Cancer Research and Therapeutics, 13, 916-929.
• Holder S, Narula N S. (2022). Common sleep disorders in adults: Diagnosis and management. American Family Physician, 105(4), 395-405.
• Howell D, Keller-Olaman S, Oliver T, Hack T, Broadfield L, Biggs K ve ark. (2013). A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Current Oncology, 20(3), 233–246.
• Inglis J E, Lin P J, Kerns S L, Kleckner I R, Kleckner A S, Castillo D A, ve ark. (2019). Nutritional interventions for treating cancer related fatigue: A qualitative review. Nutrition and Cancer, 71(1), 21-40.
• Izak M, Bussel JB. (2014). Management of thrombocytopenia. F1000Prime Reports, 6(45), 1-10.
• Jespersen KV, Koenig J, Jennum P, Vuust P. (2015). Music for insomnia in adults (review). Cochrane Database of Systematic Reviews, 8, 1-49.
• Khan SA, Davidson BR, Goldin RD, Heaton N, John Karani SP, Rosenberg WM ve ark. (2012). Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut, 61(12), 1657-1669.
• Kırdal Y. (2012). Taxan Kemoterapisi alan prostat kanseri hastalarında hemşirelik girişimleri. Üroonkoloji Bülteni, 11(2), 173-177.
• Kwekkeboom KL, Abbott-Anderson K, Cherwin C, Roiland R, Serlin RC, Ward SE. (2012). Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer. Journal of Pain and Symptom Management, 44(6), 810-822.
• Langius JA, Zandbergen MC, Eerenstein SE, Tulder MW, Leemans CR, Kramer MH ve ark. (2013). Effect of nutritional interventions on nutrition status, quality of life and mortality in patients with head and neck cancer receiving (chmeo) radiotherapy: a systematic review. Clinical Nutrition, 32(5), 671-678.
• Lee HS. (2022). Neoadjuvant and Adjuvant Chemotherapy for Cholangiocarcinoma. Korean Journal of Pancreas Biliary Tract, 27(3), 111-115.
• Lesser G J, Case D, Stark N, Williford S, Giguere J, Garino L A ve ark. (2013). A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. Journal of Supportive Oncology, 11(1), 31-42.
• Loh KP, Burhenn P, Hurria A, Zachariah F, Mohile SG. (2016). How do I best manage insomnia and other sleep disorders in older adults with cancer? Journal of Geriatric Oncology, 7(6), 413-421.
• Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM. (2013). Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer, 119(22), 3929-42.
• Medysky M E, Temesi J, Culos-Reed S N, Millet G Y. (2017). Exercise, sleep and cancer-related fatigue: Are they related? Neurophysiologie Clinique/Clinical Neurophysiology, 47(2), 111-122.
• Mustian LK, Sprod LK, Janelsins M, Peppone LJ, Palesh OG, Chandwani K ve ark. (2013). Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. Journal of Clinical Oncology, 31(26), 3233-41.
• National Comprehensive Cancer Network. (2023). Cancer-Related Fatigue. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Erişim Tarihi: 22.05.2023, https://www.nccn.org/store/login/ login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf
• Nguyen KT, Kalyan A, Beasley HS, Singhi AD, Sun W, Zeh HJ, Normolle D, Bahary N. (2017). Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of response. Journal of Gastrointestinal Oncology, 8(3), 556-565.
• O'Brien L, Loughnan A, Purcell A, Haines T. (2014 ). Education for cancer-related fatigue: could talking about it make people more likely to report it? Support Care Cancer, 22(1), 209-215.
• Palacio S, Hosein PJ, Reis I, Akunyili II, Ernani V, Pollack T, Macintyre J, Restrepo MH, Merchan JR, Lima CMR. (2018). The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology, 9(1), 135-139.
• Pancreatic Cancer UK. (2019). Nab-paclitaxel (Abraxane). Erişim Tarihi: 12.11.2022, https://www.pancreaticcancer.org.uk/information/treatments-for-pancreatic-cancer/chemotherapy/nab-paclitaxel-abraxane/.
• Rakić M, Patrlj L, Kopljar M, Kliček R, Kolovrat M, Loncar B, Busic Z. (2014). Gallbladder cancer. Hepatobiliary Surgery and Nutrition, 3(5), 221–226.
• Reid J. (2014). Psychosocial, educational and communicative interventions for patients with cachexia and their family carers. Current Opinion in Supportive and Palliative Care, 8(4), 334–338.
• Saennau, S. (2010). A Case Study: promotion of self care for cholangiocarcinoma patients receiving chemotherapy. Portal Regional da BVS. https://pesquisa.bvsalud.org/portal/resource/pt/sea-131596
• Sahai V, Catalano PJ, Zalupski MM. (2018). Nab-paclitaxel and gemcitabine as first-line treatment of advanced or metastatic cholangiocarcinoma. JAMA Oncology, 4(12), 1707-1712.
• Serra J, Mascort-Roca J, Marzo-Castillejo M, Delgado Aros S, Ferrándiz Santos J, Rey Diaz Rubio E, Mearin Manrique F. (2017). Clinical practice guidelines for the management of constipation in adults. Part 1: Definition, aetiology and clinical manifestations. Gastroenterol Hepatol, 40(3), 132-141. doi: 10.1016/j.gastrohep.2016.02.006.
• Stojanovska V, Sakkal S, Nurgali K. (2015). Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity. American Journal of Physiology-Gastrointestinal and Liver Physiology, 308(4), 223–232.
• Thomson C A, Crane T E, Miller A, Garcia D O, Basen-Engquist K, Alberts D S. (2016). A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. Contemporary Clinical Trials, 49, 181-189.
• Trill MD. (2013). Anxiety and sleep disorders in cancer patients. EJC Suppl., 11(2), 216-224.
• Van Vulpen JK, Peeters PH, Velthuis MJ, Wall EV, May AM. (2016). Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: A meta-analysis. Maturitas, 85, 104-111.
• Wickham RJ. (2017). Managing constipation in adults with cancer. Journal of the Advanced Practitioner in Oncology,8(2), 149-161.